Osteoporosis risk in premenopausal women

Pharmacotherapy

Volumn 29, Issue 3, 2009, Pages 305-317

  Vondracek, Sheryl F ^a,d   Hansen, Laura B ^a,b   McDermott, Michael T ^c  

^a University of Colorado Denver Anschutz Medical Campus   (United States)

^b Division of Endocrinology Metabolism and Diabetes   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

BMD; Bone mineral density; Dual Energy x ray absorptiometry; DXA; Osteoporosis; Premenopause

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CAFFEINE; CALCIUM; VITAMIN D;

ALCOHOL CONSUMPTION; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE MINERAL; CIGARETTE SMOKING; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FRACTURE; HABIT; HUMAN; LIFESTYLE MODIFICATION; MEDLINE; NUTRITION; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR; SCREENING; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; EXERCISE; FEMALE; FRACTURES, BONE; HUMANS; LIFE STYLE; OSTEOPOROSIS; PREMENOPAUSE; RISK FACTORS; VITAMIN D DEFICIENCY; WOMEN'S HEALTH;

EID: 62549111684     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.3.305     Document Type: Review

References (66)

1. Lewiecki EM. Low bone mineral density in premenopausal women. South Med J 2004;97:544-50.
2. Lewiecki EM. Premenopausal bone health assessment. Curr Rheumatol Rep 2005;7:46-52.
3. Khan A. Management of low bone mineral density in premenopausal women. J Obstet Gynaecol Can 2005;27:345-9.
4. Prior JC, Vigna YM, Barr SI, Kennedy S, Schulzer M, Li DK. Ovulatory premenopausal women lose cancellous spinal bone: a five-year prospective study. Bone 1996;18:261-7.
5. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss: a prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996;97:14-21.
6. Sowers M, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre-and perimenopausal white women: the Michigan bone health study. J Bone Miner Res 1998;13:1134-40.
7. Melton LJ III, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL. Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 2000;15:24-31.
8. Warming L, Hassager C, Christiansen C. Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int 2002;13:105-12.
9. Bainbridge KE, Sowers MF, Crutchfield M, Lin X, Jannausch M, Harlow SD. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002;156:410-17.
10. Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008;23:205-14.
11. Gourlay ML, Brown SA. Clinical considerations in premenopausal osteoporosis. Arch Intern Med 2004;164:603-14.
12. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-36.
13. Writing Group for the International Society for Clinical Densitometry Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 2004;7:17-26.
14. Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003;14(suppl 3):S13-18.
15. Peris P, Guanabens N, Martinez de Osaba MJ, et al. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002;32:64-70.
16. Wigderowitz CA, Cunningham T, Rowley DI, Mole PA, Paterson CR. Peripheral bone mineral density in patients with distal radial fractures. J Bone Joint Surg Br 2003;85:423-5.
17. Goulding A, Gold E, Walker R, Lewis-Barned N. Women with past history of bone fracture have low spinal bone density before menopause. N Z Med J 1997;110:232-3.
18. Hung LK, Wu HT, Leung PC, Qin L. Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop Relat Res 2005;435:219-25.
19. Honkanen R, Tuppurainen M, Kroger H, Alhava E, Puntila E. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int 1997;60:327-31.
20. Fiorano-Charlier C, Ostertag A, Aquino JP, de Vernejoul MC, Baudoin C. Reduced bone mineral density in postmenopausal women self-reporting premenopausal wrist fractures. Bone 2002;31:102-6.
21. Wu F, Mason B, Horne A, et al. Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med 2002;162:33-6.
22. Hosmer WD, Genant HK, Browner WS. Fractures before menopause: a red flag for physicians. Osteoporos Int 2002;13:337-41.
23. Salamone LM, Glynn NW, Black DM, et al. Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res 1996;11:1557-65.
24. Blum M, Harris SS, Must A, Phillips SM, Rand WM, Dawson-Hughes B. Weight and body mass index at menarche are associated with premenopausal bone mass. Osteoporos Int 2001;12:588-94.
25. Hawker GA, Jamal SA, Ridout R, Chase C. A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporos Int 2002;13:400-6.
26. Adami S, Giannini S, Giorgino R, et al. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study. Calcif Tissue Int 2004;74:317-21.
27. Bainbridge KE, Sowers M, Lin X, Harlow SD. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 2004;15:439-46.
28. Kolle E, Torstveit MK, Sundgot-Borgen J. Bone mineral density in Norwegian premenopausal women. Osteoporos Int 2005;16:914-20.
29. Liu-Ambrose T, Kravetsky L, Bailey D, et al. Change in lean body mass is a major determinant of change in areal bone mineral density of the proximal femur: a 12-year observational study. Calcif Tissue Int 2006;79:145-51.
30. Tudor-Locke C, McColl RS. Factors related to variation in premenopausal bone mineral status: a health promotion approach. Osteoporos Int 2000;11:1-24.
31. Moreira Kulak CA, Schussheim DH, McMahon DJ, et al. Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract 2000;6:296-304.
32. Strotmeyer ES, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 2006;29:306-11.
33. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, D.C., 2008. Available from http://www.nof.org/professionals/cliniciansguideform.asp. Accessed June 27, 2008.
34. Yazici KM, Akinci A, Sutcu A, Ozcakar L. Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 2003;117:271-5.
35. Khan AA, Syed Z. Bone densitometry in premenopausal women: synthesis and review. J Clin Densitom 2004;7:85-92.
36. Harper KD, Weber TJ. Secondary osteoporosis: diagnostic considerations. Endocrinol Metab Clin North Am 1998;27:325-48.
37. Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM. Depot medroxyprogesterone acetate and bone mineral density in adolescents-the black box warning: a position paper of the Society for Adolescent Medicine. J Adolesc Health 2006;39:296-301.
38. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004;35:434-41.
39. Clark MK, Sowers MR, Nichols S, Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2004;82:1580-6.
40. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005;159:139-44.
41. Cromer BA, Lazebnik R, Rome E, et al. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol 2005;192:42-7.
42. Mehler PS. Osteoporosis in anorexia nervosa: prevention and treatment. Int J Eat Disord 2003;33:113-26.
43. Miller KK, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 2006;91:2931-7.
44. do Carmo I, Mascarenhas M, Macedo A, et al. A study of bone density change in patients with anorexia nervosa. Eur Eat Disord Rev 2007;15:457-62.
45. Lucas AR, Melton LJ III, Crowson CS, O'Fallon WM. Long- term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999;74:972-7.
46. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990;86:440-7.
47. Misra M, Klibanski A. Anorexia nervosa and osteoporosis. Rev Endocr Metab Disord 2006;7:91-9.
48. Treasure J, Serpell L. Osteoporosis in young people: research and treatment in eating disorders. Psychiatr Clin North Am 2001;24:359-70.
49. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker IR. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997;151:16-21.
50. Dominguez J, Goodman L, Sen Gupta S, et al. Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses. Am J Clin Nutr 2007;86:92-9.
51. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995;80:898-904.
52. Krieg MA, Barkmann R, Gonnelli S, et al. Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD official positions. J Clin Densitom 2008;11:163-87.
53. Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the national osteoporosis risk assessment. J Bone Miner Res 2002;17:2222-30.
54. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137: 529-41.
55. Winzenberg TM, Oldenburg B, Frendin S, De Wit L, Jones G. Effects of bone density feedback and group education on osteoporosis knowledge and osteoporosis self-efficacy in premenopausal women: a randomized controlled trial. J Clin Densitom 2005;8:95-103.
56. Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 1999;14:2143-9.
57. Kulp JL, Rane S, Bachmann G. Impact of preventive osteoporosis education on patient behavior: immediate and 3- month follow-up. Menopause 2004;11:116-19.
58. U.S. Department of Health and Human Services, U.S. Department of Agriculture. Dietary guidelines for Americans, 6th ed. Washington, DC: U.S. Government Printing Office, 2005. Available from http://www.health.gov/ dietaryguidelines/dga2005/document/default.htm. Accessed February 18, 2008.
59. Peris P, Monegal A, Martinez MA, Moll C, Pons F, Guanabens N. Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol 2007;26:958-61.
60. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999;60:68-73.
61. Minsker DH, Manson JM, Peter CP. Effects of the bisphos- phonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol 1993;121:217-23.
62. Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996;18:75-85.
63. Franchimont N, Canalis E. Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease. Autoimmun Rev 2003;2:224-8.
64. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526-8.
65. Elliott ME, Meek PD, Kanous NL, et al. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc (Wash) 2002;42:101-11.
66. MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 2005;25:379-86.